Proceedings: Cancer of the prostate

Cancer. 1973 Nov;32(5):1089-91. doi: 10.1002/1097-0142(197311)32:5<1089::aid-cncr2820320512>3.0.co;2-i.
No abstract available

MeSH terms

  • Amides / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Arginase / metabolism
  • Bleomycin / pharmacology
  • Busulfan / therapeutic use
  • Carbamates / therapeutic use
  • Chromomycins / therapeutic use
  • Cyclic P-Oxides / therapeutic use
  • Cyclohexanes / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Dactinomycin / therapeutic use
  • Dimethylamines / therapeutic use
  • Drug Evaluation, Preclinical
  • Estranes / therapeutic use
  • Ethylamines / therapeutic use
  • Fluorouracil / therapeutic use
  • Humans
  • Imidazoles / therapeutic use
  • Male
  • Mitomycins / therapeutic use
  • Nitrogen Mustard Compounds / therapeutic use
  • Nitrosourea Compounds / therapeutic use
  • Organophosphorus Compounds / therapeutic use
  • Oxidoreductases / metabolism*
  • Plicamycin / therapeutic use
  • Procarbazine / therapeutic use
  • Prostate / enzymology
  • Prostatic Neoplasms / drug therapy*
  • Streptozocin / pharmacology
  • Triazines / therapeutic use
  • Uracil Mustard / therapeutic use
  • Vincristine / therapeutic use

Substances

  • Amides
  • Antineoplastic Agents
  • Carbamates
  • Chromomycins
  • Cyclic P-Oxides
  • Cyclohexanes
  • Dimethylamines
  • Estranes
  • Ethylamines
  • Imidazoles
  • Mitomycins
  • Nitrogen Mustard Compounds
  • Nitrosourea Compounds
  • Organophosphorus Compounds
  • Triazines
  • Bleomycin
  • Dactinomycin
  • Procarbazine
  • Vincristine
  • Streptozocin
  • Cyclophosphamide
  • Oxidoreductases
  • Arginase
  • Busulfan
  • Plicamycin
  • Fluorouracil
  • Uracil Mustard